STOCK TITAN

Lexicon Pharmaceuticals to Participate at Two Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Lexicon Pharmaceuticals (NASDAQ:LXRX) has announced its participation in two upcoming investor conferences in September 2025. The company will present at Citi's Biopharma Back to School Conference on September 3 at 1:45 p.m. ET and at the H.C. Wainwright 27th Annual Global Investment Conference on September 8 at 3:00 p.m. ET.

Both presentations will be available via live webcast and replay through Lexicon's investor relations website at investors.lexpharma.com.

Lexicon Pharmaceuticals (NASDAQ:LXRX) ha annunciato la sua partecipazione a due conferenze per investitori previste per settembre 2025. La società terrà una presentazione al Citi's Biopharma Back to School Conference il 3 settembre alle 13:45 ET e al H.C. Wainwright 27th Annual Global Investment Conference l'8 settembre alle 15:00 ET.

Entrambe le presentazioni saranno trasmesse in diretta via webcast e saranno disponibili in replay sul sito dedicato agli investitori di Lexicon all'indirizzo investors.lexpharma.com.

Lexicon Pharmaceuticals (NASDAQ:LXRX) ha anunciado su participación en dos conferencias para inversores en septiembre de 2025. La compañía presentará en el Citi's Biopharma Back to School Conference el 3 de septiembre a la 1:45 p.m. ET y en el H.C. Wainwright 27th Annual Global Investment Conference el 8 de septiembre a las 3:00 p.m. ET.

Ambas presentaciones estarán disponibles por webcast en directo y en reproducción en el sitio web de relaciones con inversores de Lexicon: investors.lexpharma.com.

Lexicon Pharmaceuticals (NASDAQ:LXRX)는 2025년 9월에 예정된 두 건의 투자자 컨퍼런스에 참가한다고 발표했습니다. 회사는 Citi's Biopharma Back to School Conference에서 9월 3일 동부시간 오후 1시 45분에, H.C. Wainwright 27th Annual Global Investment Conference에서 9월 8일 동부시간 오후 3시에 발표를 진행합니다.

두 발표 모두 Lexicon 투자자 관계 웹사이트 investors.lexpharma.com을 통해 생중계 및 다시보기로 시청할 수 있습니다.

Lexicon Pharmaceuticals (NASDAQ:LXRX) a annoncé sa participation à deux conférences pour investisseurs prévues en septembre 2025. La société présentera au Citi's Biopharma Back to School Conference le 3 septembre à 13h45 ET et au H.C. Wainwright 27th Annual Global Investment Conference le 8 septembre à 15h00 ET.

Les deux présentations seront diffusées en direct par webcast et en replay sur le site relations investisseurs de Lexicon : investors.lexpharma.com.

Lexicon Pharmaceuticals (NASDAQ:LXRX) hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im September 2025 angekündigt. Das Unternehmen wird am Citi's Biopharma Back to School Conference am 3. September um 13:45 Uhr ET und am H.C. Wainwright 27th Annual Global Investment Conference am 8. September um 15:00 Uhr ET präsentieren.

Beide Präsentationen werden per Live-Webcast ausgestrahlt und im Replay über die Investor-Relations-Webseite von Lexicon unter investors.lexpharma.com verfügbar sein.

Positive
  • None.
Negative
  • None.

THE WOODLANDS, Texas, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at Citi's Biopharma Back to School Conference on Wednesday, September 3 at 1:45 p.m. ET and at the H.C. Wainwright 27th Annual Global Investment Conference on Monday, September 8 at 3:00 p.m. ET.

The live events and replays of the presentations can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/.

About Lexicon Pharmaceuticals 
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through the Genome5000™ program, Lexicon’s unique genomics target discovery platform, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. Lexicon has advanced multiple medicines to market and has a pipeline of promising drug candidates in discovery and clinical and preclinical development in heart failure, neuropathic pain, obesity, cardiology, diabetes and other indications. For additional information, please visit www.lexpharma.com

For Investor and Media Inquiries
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc. 
lexinvest@lexpharma.com 


FAQ

When is Lexicon Pharmaceuticals (LXRX) presenting at Citi's Biopharma Conference 2025?

Lexicon Pharmaceuticals will present at Citi's Biopharma Back to School Conference on Wednesday, September 3, 2025 at 1:45 p.m. ET.

What time is Lexicon's presentation at the H.C. Wainwright Conference 2025?

Lexicon will present at the H.C. Wainwright Global Investment Conference on Monday, September 8, 2025 at 3:00 p.m. ET.

How can investors access Lexicon Pharmaceuticals' conference presentations?

Investors can access both the live events and presentation replays through the Events page of Lexicon's website at investors.lexpharma.com.

Which investor conferences is LXRX attending in September 2025?

LXRX is attending Citi's Biopharma Back to School Conference on September 3 and the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025.
Lexicon Pharmaceuticals Inc

NASDAQ:LXRX

LXRX Rankings

LXRX Latest News

LXRX Latest SEC Filings

LXRX Stock Data

410.64M
358.94M
1.17%
72.07%
7.45%
Biotechnology
Pharmaceutical Preparations
Link
United States
THE WOODLANDS